Trojan, Jörg
University Hospital Frankfurt
3 papers on CoChatORCID 0000-0003-4110-2647
Most cited papers
- Verified
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 4,280
- Verified
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature
Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis
Cited by 1,294
- Verified
The rubber hand universe: On the impact of methodological differences in the rubber hand illusion
Riemer, M., Trojan, J., Beauchamp, M., & Fuchs, X. (2019) · Neuroscience & Biobehavioral Reviews
Virtual Reality Applications and ImpactsTactile and Sensory Interactions
Cited by 147
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free